13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q3 2024 · Filed November 8, 2024 · Accession 0000950123-24-010641
Total Value
$90.3M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,266,934 | $55.5M | 61.51% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 20,162,332 | $27.8M | 30.81% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $6.9M | 7.68% |